DELFI Diagnostics
Biotechnology Research
Baltimore, Maryland 15,347 followers
Saving lives through early cancer detection
Meet Our Leaders
Leadership Team at Delfi Diagnostics
-
Victor Velculescu
Professor, Johns Hopkins University School of Medicine | Founder, DELFI Diagnostics
-
Jenn Buechel
President and Chief Operating Officer at Delfi Diagnostics | Aspen Health Innovators Fellow | Board Member
-
Nicholas Dracopoli
Chief Scientific Officer at Delfi Diagnostics
-
Robert Scharpf
Associate Professor of Oncology and Biostatistics, Co-Founder and Head of Data Science at Delfi Diagnostics
About Us
Delfi's technology leverages advances in machine learning and recent discoveries in the genome-wide fragmentation profiles of cell free DNA to create a novel approach to detecting evidence of a tumor from a blood sample, while also pinpointing the tumor's location in the body. Delfi is applying this platform technology to develop a range of products designed to detect specific cancers, such as lung cancer, in at-risk individuals and to identify any of multiple cancers in any individual.
Delfi Diagnostics Announces $100 Million Series A Financing! Changing the Paradigm for Early Detection of CancerJoin Us
At Delfi we know early cancer detection saves lives, so we are developing a new generation of accessible blood tests designed to accurately detect cancer when it can be cured. Our breakthroughs in understanding the biology of cancer, accelerated by our advances in artificial intelligence, allow us to tackle one of the biggest challenges in healthcare.
Check Out Our Open Roles Delfi Diagnostics In The News